Nordic-Baltic HTA Forum – what’s happening nationally, regionally and in EU?
How does Health Technology Assessments (HTA) work in each of the Nordic-Baltic countries? What collaboration exists between countries and authorities today? Get the latest updates regarding EU vs Regional vs National level decisions and ongoing initiatives.
- What is HTA and how does HTA work in each of the Nordic-Baltic countries?
- EU framework now and in the future
- Existing cross-country HTA collaborations with focus on Nordic/Baltics
- Innovation and Affordability balance – how can we truly make it work?
Confirmed speakers and moderators:
Niklas Hedberg, The Dental and Pharmaceutical Benefits Agency (Sweden), EUnetHTA
Trine Ann Behnk, Amgros I/S (Denmark)
Name to be announced, Strategic Advisor from Amgros I/S (Denmark)
Antra Fogele, State Agency of Medicines (Latvia)
Tomas Lasys, previously at State Medicines Control Agency (Lithuania)
Ott Laius, State Agency of Medicines (Estonia)
Piia Rannanheimo, Finnish Medicines Agency (Finland)
Einar Andreassen, The Norwegian Medicines Agency (Norway)
Jonas Vikman, Lif, the research-based pharmaceutical industry (Sweden)